We are pleased to announce that Jennifer Che, Managing Director of Eagle IP, was a featured panelist at the annual Fordham Intellectual Property Law & Policy Conference held recently in New York City.

Widely regarded as one of the most prestigious gatherings in the IP world, the Fordham Conference brings together judges, practitioners, and policymakers from across the globe to discuss the most pressing issues in the field. Jennifer contributed her expertise to the China panel, where she engaged in a deep-dive discussion regarding the rapidly shifting intellectual property landscape in the region.

At Eagle IP, we remain committed to staying at the forefront of international IP policy. Jennifer’s participation in this high-level forum underscores our dedication to providing our clients with the most current and sophisticated counsel for their global IP portfolios.

Our Past Events

Recommended Insights

china-joins-two-wipo-treaties

China Joins Two WIPO Treaties, the Hague System and the Marrakesh Treaty

11 February 2022
It has been two challenging years, yet there are many reasons to still have hope. We wish you a blessed Lunar New Year as we welcome the year of the Tiger. We wanted to highlight a few new developments in China. China has joined the Hague System for the International Registration of Industrial Designs, submitting […]

IP Strategies for the Newly Released Implementation Regulations of the 4th Amendment of the Chinese Patent Law: Part 1: Delayed Examination

25 January 2024
December 2023 appears to have been an exceptionally busy and fruitful month in the China patent space. Following the State Council’s approval of the long-awaited Patent Law Implementation Regulations (“Regulations”, similar to the CFR in the US) in November, the CNIPA finally made public the full text of the Regulations just before the arrival of […]

Major and Exciting Changes to China’s Patent Law [Fourth Amendment to China's Patent Law]

20 February 2019
Major changes are on the horizon for China’s Patent Law, which will see an overhaul in many areas as early as this year (2019). On January 4, 2019, the National People’s Congress in China published the latest draft of the Fourth Amendment to China’s Patent Law. Several draft amendments have been released for public comment […]

Beijing IP Court Reverses CNIPA Decision and Upholds Ozempic® semaglutide patent in China as VALID based on Novo Nordisk’s Post Filing Data

27 June 2024
Recently, all eyes have been on China as the fundamental patent covering semaglutide, the active ingredient in Ozempic® and Wegovy®, will expire on March 20, 2026. It goes without saying that generics are ramping up bigtime in China (and also around the world), preparing to manufacture and sell this blockbuster drug to one of the […]
Top crossarrow-right